Statins for primary prevention in people with a 10% 10-year cardiovascular risk: too much medicine too soon?
作者信息
Yerrakalva Dharani, Griffin Simon J
机构信息
Department of Primary Care and Public Health, University of Cambridge, Cambridge.
出版信息
Br J Gen Pract. 2017 Jan;67(654):40-41. doi: 10.3399/bjgp17X688789.
Abstract
摘要
相似文献
1
Statins for primary prevention in people with a 10% 10-year cardiovascular risk: too much medicine too soon?他汀类药物用于10年心血管疾病风险为10%人群的一级预防：用药过早、用药过多？
Br J Gen Pract. 2017 Jan;67(654):40-41. doi: 10.3399/bjgp17X688789.
2
Statins for primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。
BMJ. 2014 May 27;348:g3491. doi: 10.1136/bmj.g3491.
3
New statin guidelines: do they apply to you?新的他汀类药物指南：它们适用于你吗？
Harv Health Lett. 2014 Feb;39(4):8.
4
Statins: new American guidelines for prevention of cardiovascular disease.他汀类药物：美国预防心血管疾病的新指南
Lancet. 2013 Nov 30;382(9907):1762-5. doi: 10.1016/S0140-6736(13)62388-0. Epub 2013 Nov 20.
5
NICE sticks to its advice to drop threshold for prescribing statins.英国国家卫生与临床优化研究所坚持其降低开具他汀类药物处方门槛的建议。
BMJ. 2014 Jul 17;349:g4694. doi: 10.1136/bmj.g4694.
6
Are statins effective in high-risk primary prevention?他汀类药物在高危一级预防中是否有效？
Arch Intern Med. 2010 Dec 13;170(22):2042-3; author reply 2043-4. doi: 10.1001/archinternmed.2010.458.
7
Statins, risk assessment, and the new American prevention guidelines.他汀类药物、风险评估与美国新的预防指南。
Lancet. 2014 Feb 15;383(9917):600-2. doi: 10.1016/S0140-6736(13)62348-X. Epub 2013 Dec 4.
8
Statins and all-cause mortality in high-risk primary prevention: a second look at the results.他汀类药物与高危一级预防中的全因死亡率：对结果的再审视
Arch Intern Med. 2010 Dec 13;170(22):2041-2; author reply 2043-4. doi: 10.1001/archinternmed.2010.456.
9
Statins for primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。
BMJ. 2019 Oct 16;367:l5674. doi: 10.1136/bmj.l5674.
10
Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials.他汀类药物用于老年患者心血管事件的一级预防：来自临床实践的情况，缺乏临床试验的确凿证据。
J Am Geriatr Soc. 2008 Jan;56(1):175-7. doi: 10.1111/j.1532-5415.2007.01486.x.
引用本文的文献
1
Association Between Long-term Statin Therapy and New-onset Diabetes in Cardiovascular Risk Patients in the UAE.阿联酋心血管疾病风险患者长期他汀类药物治疗与新发糖尿病之间的关联
Oman Med J. 2024 Nov 30;39(6):e690. doi: 10.5001/omj.2024.109. eCollection 2024 Nov.
本文引用的文献
1
Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data.他汀类药物相关媒体报道对他汀类药物使用的影响：基于英国初级医疗数据的中断时间序列分析
BMJ. 2016 Jun 28;353:i3283. doi: 10.1136/bmj.i3283.
2
Statin tolerability: In defence of placebo-controlled trials.他汀类药物的耐受性：为安慰剂对照试验辩护。
Eur J Prev Cardiol. 2016 May;23(8):891-6. doi: 10.1177/2047487315602861. Epub 2015 Aug 28.
3
Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk.估计的10年心血管死亡率严重低估了总体心血管风险。
Heart. 2016 Jan;102(1):63-8. doi: 10.1136/heartjnl-2015-307668. Epub 2015 Aug 10.
4
What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice.服用他汀类药物的患者中，有症状的副作用真正由药物引起的比例是多少？对随机安慰剂对照试验进行系统评价以帮助个体患者做出选择。
Eur J Prev Cardiol. 2014 Apr;21(4):464-74. doi: 10.1177/2047487314525531. Epub 2014 Mar 12.
5
Exercise-induced myalgia may limit the cardiovascular benefits of statins.运动引起的肌肉疼痛可能会限制他汀类药物的心血管益处。
Cardiovasc Drugs Ther. 2013 Dec;27(6):569-72. doi: 10.1007/s10557-013-6483-8.
6
Statins for the primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004816. doi: 10.1002/14651858.CD004816.pub5.
7
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.他汀类药物降低 LDL 胆固醇对低血管疾病风险人群的影响：27 项随机试验个体数据的荟萃分析。
Lancet. 2012 Aug 11;380(9841):581-90. doi: 10.1016/S0140-6736(12)60367-5. Epub 2012 May 17.
8
Helping patients decide: ten steps to better risk communication.帮助患者决策：改善风险沟通的十步骤。
J Natl Cancer Inst. 2011 Oct 5;103(19):1436-43. doi: 10.1093/jnci/djr318. Epub 2011 Sep 19.
9
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.他汀类药物与新发糖尿病风险：随机他汀类药物试验的协作荟萃分析。
Lancet. 2010 Feb 27;375(9716):735-42. doi: 10.1016/S0140-6736(09)61965-6. Epub 2010 Feb 16.
10
Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.在一项针对20536名高危人群开展的为期5年的随机安慰剂对照试验中，每日服用40毫克辛伐他汀对肌肉和肝脏不良反应的影响。
BMC Clin Pharmacol. 2009 Mar 31;9:6. doi: 10.1186/1472-6904-9-6.
Zotero 插件